Use of Rotational Thromboelastometry With Ristocetin to Identify Clinically Relevant von Willebrand Disease
Using rotational thromboelastometry may allow assessment of bleeding risks in patients with clinically relevant von Willebrand disease.
Using rotational thromboelastometry may allow assessment of bleeding risks in patients with clinically relevant von Willebrand disease.
The interactions between von Willebrand factors and its cleaving protease ADAMTS-13 recently emerged as risk factors for pediatric thromboembolism.
Researchers comment on the implications of treating newborns and infants with von Willebrand factor (VWF) concentrate.